Package 82868-041-90

Brand: amlodipine besylate and benazepril hydrochloride

Generic: amlodipine besylate and benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 82868-041-90
Digits Only 8286804190
Product NDC 82868-041
Description

90 CAPSULE in 1 BOTTLE, PLASTIC (82868-041-90)

Marketing

Marketing Status
Marketed Since 2024-01-19
Brand amlodipine besylate and benazepril hydrochloride
Generic amlodipine besylate and benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46dcb5ee-e8ae-9a1a-e063-6294a90a5fa5", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342"], "spl_set_id": ["106c08c2-90eb-6bc0-e063-6294a90a5a23"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE, PLASTIC (82868-041-90)", "package_ndc": "82868-041-90", "marketing_start_date": "20240119"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "82868-041_46dcb5ee-e8ae-9a1a-e063-6294a90a5fa5", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "82868-041", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA077183", "marketing_category": "ANDA", "marketing_start_date": "20240119", "listing_expiration_date": "20261231"}